3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Dysplasia
1
Papillomavirus Infections
1
Infections
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
16
Papillomavirus Vaccines
12
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Vaccines
5
Human Papillomavirus DNA Tests
5
Colposcopy
5
Specimen Handling
4
Blood Specimen Collection
4
Watchful Waiting
3
Vaginal Smears
3
Patient Navigation
3
Engerix-B
3
Educational Status
3
fludarabine phosphate
2
fludarabine
2
artesunic acid
2
artemisinin
2
aldesleukin
2
Vaccines, Synthetic
2
Standard of Care
2
Practice Guidelines as Topic
2
Polymerase Chain Reaction
2
Mass Screening
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
GX-188 vaccine
2
Early Intervention, Educational
2
Data Collection
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
Olive Oil
×
Gynecologic
×
Clear all
NCT02346227
2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3
Completed
327 enrolled